Press Releases
Press Releases
Ferrer submits IND for Arasertaconazole nitrate, a safe, fast-acting topical antifungal in development for Vulvovaginal Candidiasis
Ferrer, a privately-held Spanish pharmaceutical company with full vertical integration from R&D to commercialisation, announces today that it has filed an IND for its topical antifungal agent Arasertaconazole nitrate. The agent has recently demonstrated...
Press Releases
Exactech Announces Investor Presentation at Canaccord Genuity Growth Conference
Exactech, Inc., a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials will update investors at the 2012 Canaccord Genuity Growth Conference in Boston on Tuesday, August 14, 2012. ...
Press Releases
TekPartners/MedPartners HIM Ranked #4 in Top 100 Best Companies List
TekPartners/MedPartners HIM was named #4 Best Company To Work For in Florida by Florida Trend for the 2nd consecutive year. The focus of the 2012 interview panel was based on effective hiring practices. The evaluation process also included...
Press Releases
Antiepileptic Drugs Are the Most Commonly Prescribed Drug Class Among Newly Diagnosed Bipolar Disorder Patients in the United States
Decision Resources, one of the world’s leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds through examination of U.S. patient-level claims data, thatantiepileptic drugs (AED) are the most commonly prescribed drug class among newly diagnosed...
Press Releases
The Development of Combination Therapies to Treat Viral Diseases is Key to Future Treatment and the Focus of Recent Pharma Collaborations
Decision Resources, one of the world’s leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that the development of combination therapies for hepatitis c virus (HCV) and fixed-dose combinations and single-tablet regimens for human immunodeficiency...
Press Releases
Trophos announces conclusion of MitoTarget Consortium, achieving advanced understanding of neurodegenerative diseases
Trophos SA, a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation for indications with under-served needs in neurology and cardiology, announces today the conclusion of the pan-European MitoTarget Project, the EU funded orphan disease project,...
Press Releases
Healthy Life Screening Announces New Venture with Akron General Medical Center
Healthy Life Screening is partnering with Akron General Medical Center to provide preventive cardiovascular and biometric screening services to corporations, patients and the Northeast Ohio community. The mission and vision of this partnership will help...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read